e-Drug3D

693

FELBAMATE


INN
FELBAMATE

cas 25451-15-4
CLASS

NERVOUS SYSTEM
ANTICONVULSANT
ANTIEPILEPTIC AGENTS
NEUROPROTECTIVE AGENTS

ROUTE (list)

ORAL

ATC code

N03AX10

PK parameters

F 90 PERCENT
VD 49.1 LITER (65 KILOGRAM)
Cl 1.6 LITER / HOUR (65 KILOGRAM)
PPB 25 PERCENT
t1/2 21.5 HOUR

Solubility

VERY SLIGHTLY SOLUBLE IN WATER


Target

TARGET GLUTAMATE [NMDA] RECEPTOR

DrugCentral

Glutamate receptor ionotropic, NMDA 2A UNIPROT Q12879 GRIN2A

Glutamate receptor ionotropic, NMDA 2B UNIPROT Q13224 GRIN2B

Download SDF file (3-carbamoyloxy-2-phenylpropyl) carbamate

Formula:
C11H14N2O4

Calculated chemical properties:

MW 238.24
NB_atoms 17
XLogP 0.96
PSA 101.561
NB_HD 4
NB_HA 6
fsp3 0.27
Lipinski(0=no;1=yes) 1

FDA
NDA 020189 (pdf not found) INN (FELBAMATE) FELBATOL (MYLAN SPECIALITY LP) APPROVAL= AP YEAR= 1993
NDA 201680 (pdf not found) INN (FELBAMATE) FELBAMATE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2011
NDA 202385 (pdf not found) INN (FELBAMATE) FELBAMATE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2011
NDA 202284 (pdf not found) INN (FELBAMATE) FELBAMATE (ANI PHARMS) APPROVAL= AP YEAR= 2015
NDA 204595 (pdf not found) INN (FELBAMATE) FELBAMATE (ALVOGEN) APPROVAL= AP YEAR= 2016 DISCONTINUED
NDA 206314 (pdf not found) INN (FELBAMATE) FELBAMATE (TARO) APPROVAL= AP YEAR= 2017
NDA 207093 (pdf not found) INN (FELBAMATE) FELBAMATE (TARO) APPROVAL= AP YEAR= 2017
NDA 208970 (pdf not found) INN (FELBAMATE) FELBAMATE (ZYDUS LIFESCIENCES) APPROVAL= AP YEAR= 2017
NDA 211333 (pdf not found) INN (FELBAMATE) FELBAMATE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2019

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL